Open AccessImmune subgroups and the tumor microenvironment as a potential new biomarker to assess response to immunotherapy
Author(s) -
Shawn Kothari,
Everett E. Vokes
Publication year - 2019
Publication title -
chinese clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.733
H-Index - 22
eISSN - 2304-3873
pISSN - 2304-3865
DOI - 10.21037/cco.2019.08.15
Subject(s) - pembrolizumab , medicine , immunotherapy , tumor microenvironment , head and neck squamous cell carcinoma , oncology , chemotherapy , biomarker , immune system , first line , immunology , cancer , head and neck cancer , biochemistry , chemistry